A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 26 May 2017
At a glance
- Drugs Romidepsin (Primary)
- Indications T cell lymphoma
- Focus Therapeutic Use
- Sponsors Memorial Sloan-Kettering Cancer Center
- 05 Jan 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 05 Jan 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 31 Jul 2013 New source identified and integrated: Memorial Sloan-Kettering Cancer Center record.